Legacy Financial Advisors, Inc. Biogen Inc. Transaction History

Legacy Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $95,171 - $104,906	-434 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $4,767 - $7,457	-22 Reduced 4.82%	434 $103,000
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $27,571 - $34,922	-99 Reduced 17.84%	456 $137,000
Q2 2018 Jul 17, 2018	SELL	$257.52 - $306.91 $80,861 - $96,369	-314 Reduced 36.13%	555 $193,000
Q1 2018 Apr 12, 2018	BUY	$260.13 - $367.91 $226,052 - $319,713	869 New	869 $230,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.